Applied Biosystems Deutschland GmbH
Applied Biosystems Deutschland GmbH: Announcement of the decision to submit a voluntary public offer
Applied Biosystems Deutschland GmbH / Miscellaneous 09.04.2010 08:45 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer / publisher is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Announcement of the decision to submit a voluntary public offer for the purchase of all shares in GENEART AG in corresponding consideration of the content of Sections 10 (1), 29 (1), 34 German Securities Acquisition and Takeover Act (WpÜG) Bidder: Applied Biosystems Deutschland GmbH Frankfurter Straße 129B D-64293 Darmstadt E-Mail: tender@appliedbiosystems.com registered with the commercial register of the local court of Darmstadt under HRB 85915 Target Company: GENEART AG Josef-Engert-Straße 11 D-93053 Regensburg Tel.: +49 (0)941 942 76-100 Fax: +49 (0)941 942 76-780 registered with the commercial register of the local court of Regensburg under HRB 10111 ISIN DE000A0JJ4L4 (WKN A0JJ4L) In corresponding consideration of the WpÜG the offer document is expected to be published shortly on the internet at http://www.G6Atender.com. Statement of the Bidder: Today Applied Biosystems Deutschland GmbH (Bidder) decided to offer to the shareholders of GENEART AG, by way of a voluntary public offer, to purchase the shares in GENEART AG (GENEART Shares) held by them (Offer). The Offer will be subject to the terms and conditions to be indicated in the offer document. The Bidder intends to offer to the shareholders of GENEART AG to purchase their GENEART Shares with a par value of EUR 1.00 by way of a voluntary public offer in return for payment of an amount of EUR 13.75 per GENEART Share, subject to the provisions of the offer document. With effect of 9 April 2010 the Bidder has acquired, inter alia from GENEART AG's founding shareholders Prof Dr Ralf Wagner, Prof Dr Hans Wolf and Dr Marcus Graf, a total of 2,631,552 shares, and thus approximately 58.64% of all shares in GENEART AG, by way of a share purchase off exchange at a price of EUR 11.59 per share. Important information: The WpÜG is not applicable on the Offer. Therefore, the offer document will not be reviewed by the German Federal Financial Supervisory Authority (BaFin). This announcement neither stipulates an offer to purchase nor an invitation to submit a tender for the sale of shares of GENEART AG. The Offer's final terms as well as any further provisions in connection with the Offer will be contained in the offer document. Investors and shareholders of GENEART AG are strongly recommended to read the offer document as well as any other documents in connection with the Offer as soon as they have been published, as these will contain important information. Darmstadt, 9 April 2010 Applied Biosystems Deutschland GmbH The Managing Directors - End of Publication - 09.04.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Media archive at www.dgap-medientreff.de and www.dgap.de ---------------------------------------------------------------------------
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden